One in twelve physicians, and nearly one in five family medicine physicians, accepted payments from pharmaceutical companies related to opioids, according to a study from Boston Medical Center's Graysen Center for Addiction Medicine and published in the American Journal of Public Health. This is the first large-scale, national study of industry payments involving opioids and suggests that pharmaceutical companies may have a stronger hold than previously known on how doctors prescribe the powerful drugs. 

Poll Question:
Do you think physicians who receive drug-firm payments related to opioids run the risk of overprescribing these medications?



Not Sure

Previous articleMalware Hidden in Synthetic DNA Could Infect Sequencing Systems
Next articleCalorie-Controlled Diet Restores Youthful Rhythmic Control of Metabolism in Old Mice